FDA Inspection 1177256 — Regenerative Biologics Inc.
The FDA completed an inspection of Regenerative Biologics Inc. on Aug 1, 2022 in Fort Myers, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 1, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Fort Myers, FL (United States)